Clinical Trial: Comparison of Osteoporosis Disease Management Strategies

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck
ClinicalTrials.gov Identifier: NCT00145080

Purpose

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.
Condition Intervention
Osteoporosis
 Behavior: Disease Management Assessment

MedlinePlus related topics:  Osteoporosis

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment

Official Title: Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization

Further Study Details: 
Primary Outcomes: Bone mineral density screening rates
Secondary Outcomes: Medications adoptions; Medications adherence
Expected Total Enrollment:  4685

Study start: July 2004

Eligibility

Ages Eligible for Study:  50 Years   -   64 Years,  Genders Eligible for Study:  Female
Criteria

Inclusion Criteria:

  • Members of the Harvard Pilgrim Health Plan

Exclusion Criteria:

  • Individuals who are not members of the Harvard Pilgrim Health Plan

Location Information

Study chairs or principal investigators

Medical Monitor,  Study Director,  Merck   

More Information

Study ID Numbers:  2005_050
Last Updated:  September 7, 2005
Record first received:  September 1, 2005
ClinicalTrials.gov Identifier:  NCT00145080
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13



Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us